ロード中...
HDAC inhibitors enhance the immunotherapy response of melanoma cells
We focused on the ability of the pan-histone deacetylase (HDAC) inhibitors AR42 and sodium valproate to alter the immunogenicity of melanoma cells. Treatment of melanoma cells with HDAC inhibitors rapidly reduced the expression of multiple HDAC proteins as well as the levels of PD-L1, PD-L2 and ODC,...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5669957/ https://ncbi.nlm.nih.gov/pubmed/29137331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17950 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|